Company is heavily stacked with Positive Results from Covid Trials carried out at 3 Independent 3rd Party Research Institutes.
Best Headline is the Covid Treatment actually works on the SARs and SARs2 Viral Family so covers mutations and variants of Covid.
K9 Trials was the 3rd carried out , again Regression in some tumors , Reduced lesions & stasis gained in others.
MPL dosing has been refined through multiple Trials.
Company has completed a First In World Flux Capacitor
Human Phase II Oncology Trial scheduled for late next year
Human Covid Trial Scheduled Q2 2022
Human MND Trial Scheduled Q2 2022
MPL in Manufacture................ Pills for first 2 Trials will be manufactured by Syngene , Human Phase II Oncology Pills to be Manufactured by Catalent.
Actually 18 months of positive Trials to date
Yes, I would say you are correct ,, messaging does leave a LOT to be desired..... current SP certainly doesn't reflect progress ,NZT
Ann: Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed, page-135
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.5¢ | 17.5¢ | $427.5K | 2.394M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 103443 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 130237 | 3 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
0.005 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 18.5¢ | 17.5¢ | 1774886 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| PAA (ASX) Chart |